Epidemiology and Public Health Study Designs, Measures, and Causal Inference

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/86

flashcard set

Earn XP

Description and Tags

Comprehensive practice vocabulary flashcards covering epidemiologic study designs (descriptive, cross-sectional, ecological, case-control, cohort, and experimental), sampling strategies, morbidity/mortality measures, validity, bias, confounding, and causal inference.

87 Terms

1
New cards

Descriptive Epidemiology

An epidemiologic approach whose goal is to characterize the amount and distribution of health and disease within a population by person, place, and time to alert researchers to emerging problems, indicate the extent and severity of disease, and suggest potential solutions.

2
New cards

Analytic Epidemiology

An epidemiologic approach whose goal is to test specific etiologic hypotheses regarding causal associations between exposures and health outcomes to identify what interventions work or do not work.

3
New cards

Case Report

A detailed descriptive epidemiologic report documenting the clinical profile and medical history of a single individual patient (n=1n = 1).

4
New cards

Case Series

A descriptive epidemiologic study that tracks and describes clinical characteristics and outcomes across a small group of patients presenting with the same diagnosis or condition.

5
New cards

Cross-Sectional Study

An observational study design that assesses exposure and disease status simultaneously in a defined sample or population at one specific point in time, providing a snapshot to assess prevalence.

6
New cards

Ecological Study

An observational study in which the unit of analysis is a group or population (typically defined geographically by countries, states, or counties) rather than individuals, using aggregate measures for both exposures and outcomes.

7
New cards

Ecological Fallacy

A logical bias that occurs when an association observed between aggregate-level variables at the group or population level is incorrectly assumed to hold true for individuals within those groups.

8
New cards

Pearson's Correlation Coefficient (rr)

A statistical measure for two continuous, quantitative variables assessing direction (r>0r > 0 for positive, r=0r = 0 for none, and r<0r < 0 for negative) and magnitude on a scale ranging from −1.0-1.0 to +1.0+1.0, where values between 0.70.7 and 1.01.0 (or −0.7-0.7 and −1.0-1.0) indicate strong association.

<p>A statistical measure for two continuous, quantitative variables assessing direction ($$r > 0$$ for positive, $$r = 0$$ for none, and $$r < 0$$ for negative) and magnitude on a scale ranging from $$-1.0$$ to $$+1.0$$, where values between $$0.7$$ and $$1.0$$ (or $$-0.7$$ and $$-1.0$$) indicate strong association.</p>
9
New cards

Simple Random Sampling

A probability sampling strategy where every element in the target population has an equal probability of selection, identified through a random number table or computer generator.

10
New cards

Systematic Sampling

A probability sampling method in which sampling elements are chosen at regular intervals through a calculated sampling interval (k=Nnk = \frac{N}{n}), beginning at a randomly selected start point.

11
New cards

Stratified Sampling

A probability sampling method where the target population is first divided into mutually exclusive subgroups (strata) based on specific characteristics (e.g., sex, race, urbanicity), followed by random sampling within each stratum to ensure proportional representation.

12
New cards

Cluster Sampling

A probability sampling technique where naturally occurring units containing multiple sampling elements (such as city blocks, schools, or clinics) are selected as the sampling elements, useful for dispersed populations lacking an exhaustive sampling frame.

13
New cards

Random Digit Dialing (RDD)

A telephone survey probability sampling technique in which researchers identify regional area codes and telephone exchanges, randomly generating the remaining four digits to recruit participants without relying on a published directory.

14
New cards

Prevalence

The proportion of a population that has a specific disease or condition at a given time, calculated as Prevalence=# existing cases (including new cases)Total population×rate base\text{Prevalence} = \frac{\text{\# existing cases (including new cases)}}{\text{Total population}} \times \text{rate base}, useful for measuring disease burden and allocating healthcare resources.

15
New cards

Point Prevalence

The proportion of a population that has a disease or health condition assessed at one single, specific point in calendar time.

16
New cards

Period Prevalence

The proportion of a population that exhibits a disease or health condition at any point over a specified span or window of time.

17
New cards

Incidence

The rate of transition from a non-diseased state to a diseased state over a specified follow-up period, calculated as Incidence=# new casesPopulation at risk over a time period×rate base\text{Incidence} = \frac{\text{\# new cases}}{\text{Population at risk over a time period}} \times \text{rate base}, and useful for identifying risk factors.

18
New cards

Bathtub Model of Disease

A steady-state conceptual framework expressing the dynamic relationship Prevalence=Incidence×Duration\text{Prevalence} = \text{Incidence} \times \text{Duration} (P=I×DP = I \times D), where new incident cases flow in like water from a tap, pool as existing prevalence, and exit through cure or mortality.

<p>A steady-state conceptual framework expressing the dynamic relationship $$\text{Prevalence} = \text{Incidence} \times \text{Duration}$$ ($$P = I \times D$$), where new incident cases flow in like water from a tap, pool as existing prevalence, and exit through cure or mortality.</p>
19
New cards

Age-Adjusted Rate

A summary morbidity or mortality rate derived by statistical standardization procedures to remove the confounding effect of differences in age composition when comparing two or more distinct populations.

20
New cards

Age-Specific Rate

A disease frequency rate calculated exclusively within a designated age bracket by dividing the number of cases in that age group by the total population within that same age group.

21
New cards

Secular Trends

Gradual changes in the frequency and occurrence of disease or mortality that unfold consistently over extensive time periods spanning multiple decades or centuries.

22
New cards

Cyclic (Seasonal) Trends

Recurrent increases and decreases in the incidence or prevalence of an illness over recurring periods within a calendar year or across intervals of several years.

23
New cards

Point Epidemic

An outbreak or epidemic curve indicating that an exposed group was affected almost simultaneously by a common, circumscribed source of infection, contamination, or etiologic agent.

24
New cards

Clustering

An unusual aggregation of health events or cases of disease that are closely grouped together in space, in time, or in both space and time.

25
New cards

Case-Control Study

An observational analytic study design in which participants are selected based on whether they have the disease (cases) or are free of the disease (controls), and their previous exposure histories are retrospectively gathered and compared.

26
New cards

"WOULD" Criterion

The fundamental guideline for control selection in case-control research: if an individual selected as a control had developed the outcome of interest during the study interval, they would have been eligible and identified as a case in the study.

27
New cards

Matched Case-Control Study

A case-control study design in which controls are paired with cases based on shared confounding characteristics, performed either on an individual level (e.g., matching a case to a control within ±2\pm 2 years of age) or frequency level (matching strata distributions).

28
New cards

Odds Ratio (OROR)

The measure of association used in case-control studies defined as the odds of disease among exposed individuals divided by the odds of disease among unexposed individuals, computed from a standard 2×22 \times 2 table as OR=a×db×cOR = \frac{a \times d}{b \times c}.

29
New cards

Cohort Study

An observational study design where a disease-free group of individuals is classified based on exposure status and tracked over time to determine and compare the incidence of one or more health outcomes.

30
New cards

Prospective Cohort Study

A cohort design in which exposure status is evaluated at the start of the study, and participants are followed forward in time into the future to identify incident disease cases.

31
New cards

Retrospective Cohort Study

A cohort design in which both exposure and outcome have already occurred prior to the initiation of the study, reconstructed historically using existing baseline and medical records.

32
New cards

Ambidirectional Cohort Study

A hybrid cohort design that uses historical records to capture past exposures and outcomes while simultaneously following the established cohort forward in time into the future.

33
New cards

Framingham Heart Study

A landmark population-based prospective cohort study initiated in 1948 by the NHLBI that enrolled 5,209 adult residents of Framingham, Massachusetts to track cardiovascular disease risk factors across generations.

34
New cards

Air Force Ranch Hand Study

A special occupational cohort study evaluating long-term adverse health outcomes among 2,483 military service personnel who flew or supported C-123 aircraft spraying Agent Orange during the Vietnam conflict from 1962 to 1971.

35
New cards

Counterfactual

The theoretical ideal state representing what the disease risk would have been among exposed individuals had they simultaneously not been exposed, approximated in observational epidemiology through unexposed comparison groups.

36
New cards

Relative Risk (RRRR)

The ratio of the cumulative incidence of disease in an exposed cohort group to the cumulative incidence of disease in an unexposed comparison group: RR=CIECIU=a/(a+b)c/(c+d)RR = \frac{CI_E}{CI_U} = \frac{a / (a + b)}{c / (c + d)}.

37
New cards

Attributable Risk (ARAR)

The measure of absolute excess disease risk among exposed individuals that is directly attributable to the exposure: AR=CIE−CIU=aa+b−cc+dAR = CI_E - CI_U = \frac{a}{a + b} - \frac{c}{c + d}.

38
New cards

Attributable Risk Percent (AR%AR\%)

The proportion of disease incidence in the exposed cohort that could be eliminated if the exposure were completely removed: AR%=(CIE−CIUCIE)×100AR\% = \left(\frac{CI_E - CI_U}{CI_E}\right) \times 100.

39
New cards

Risk Difference (RDRD)

A measure of public health impact reflecting the absolute excess cases in the exposed group relative to the unexposed group per unit population: RD=(aa+b−cc+d)×rate baseRD = \left(\frac{a}{a + b} - \frac{c}{c + d}\right) \times \text{rate base}.

40
New cards

Randomized Controlled Trial (RCT)

An experimental investigation in which the researcher randomly allocates eligible human participants to either an active intervention arm or a comparison arm (placebo, standard of care, or no treatment) to test causal efficacy.

41
New cards

Quasi-Experimental Study

An experimental study design where the researcher manipulates the exposure or intervention but does not randomly assign individual subjects to study arms, often relying on naturally or opportunistically formed groups.

42
New cards

Cross-Over Design

An experimental trial in which each subject receives multiple consecutive interventions in a planned sequence, switching between active treatment and control arms partway through the trial.

43
New cards

Cluster-Randomized Trial

An experimental trial in which intact social or administrative groups (such as clinics, schools, or geographic areas) are randomized to intervention or control arms rather than individual participants.

44
New cards

Community Trial

A subtype of quasi-experimental study designed to evaluate the real-world impact of a health promotion policy, educational campaign, or environmental intervention delivered across an entire defined community.

45
New cards

Natural Experiment

An observational condition resembling an experiment where exposure levels vary across population subsets due to external forces outside the researcher's control, such as state-level policy variations or environmental events.

46
New cards

Randomization

The process of allocating enrolled trial participants to treatment or control arms by chance, ensuring that each participant has an equal probability of assignment and balancing both measured and unmeasured confounders at baseline.

47
New cards

Placebo

An inert substance, procedure, or sham intervention designed to resemble the active treatment in appearance and administration without possessing specific pharmacological or therapeutic properties.

48
New cards

Placebo Effect

A measurable physical or psychological improvement in health status observed in control group participants attributable to expectations, beliefs, and the power of suggestion rather than the active treatment.

49
New cards

Nocebo Effect

The development of adverse side effects or worsening of symptoms in a control patient receiving an inactive substance, caused by negative expectations and anticipatory anxiety.

50
New cards

Double-Blind Design

A masking methodology employed in clinical trials where neither the study participants nor the investigators interacting with them know which treatment group the participants have been assigned to.

51
New cards

Compliance

The degree to which study participants adhere strictly to the prescribed intervention protocol and schedule throughout the duration of a clinical trial.

52
New cards

Equipoise

A state of genuine clinical uncertainty among investigators regarding whether one intervention is superior to another, accompanied by the belief that withholding the experimental treatment will not harm participants.

53
New cards

Belmont Report

A 1978 foundational ethical report issued by the National Commission establishing three core principles governing research involving human subjects: Respect for Persons, Beneficence, and Justice.

54
New cards

Respect for Persons

An ethical principle outlined in the Belmont Report requiring that individual autonomy be acknowledged and honored through voluntary informed consent, with additional protections for vulnerable populations.

55
New cards

Beneficence

An ethical principle from the Belmont Report obligating investigators to maximize tangible research benefits while minimizing physical, psychological, and social harms.

56
New cards

Justice

An ethical principle from the Belmont Report requiring the fair and equitable distribution of research burdens and benefits, ensuring groups selected for study are positioned to benefit from the findings.

57
New cards

Epidemiologic Study Design Algorithm

A hierarchical decision-tree framework used to identify epidemiologic study designs by sequentially assessing the unit of analysis, exposure assignment, sample identification method, and temporal direction.

<p>A hierarchical decision-tree framework used to identify epidemiologic study designs by sequentially assessing the unit of analysis, exposure assignment, sample identification method, and temporal direction.</p>
58
New cards

Koch's Postulates

A classical four-point microbiological causal framework requiring that an agent be present in all disease cases, isolated in pure culture, capable of inducing disease when inoculated into a healthy host, and recoverable from that host.

59
New cards

Temporality

The sole non-negotiable criterion among Hill's criteria of causation, dictating that the exposure must precede the onset of the disease in chronological sequence.

60
New cards

Biological Gradient

A Hill criterion of causation demonstrated when increasing or decreasing levels of an exposure lead to a proportional, monotonic change in the risk or severity of the outcome (dose-response curve).

61
New cards

Specificity of Association

A Hill criterion positing that causation is strengthened when an exposure produces a single distinct outcome rather than multiple disparate conditions.

62
New cards

Consistency

A Hill criterion of causation met when the observed association is repeatedly demonstrated across different research investigators, geographic locations, target populations, and study methodologies.

63
New cards

Plausibility

A Hill criterion met when an observed epidemiological relationship is supported by an understood biological or physiological mechanism grounded in existing scientific knowledge.

64
New cards

Coherence

A Hill criterion satisfied when the cause-and-effect narrative does not conflict with the known natural history, biology, and laboratory findings of the disease.

65
New cards

Deterministic Causality

A causal model stating that a given cause is invariably followed by a specific effect, categorized according to whether the cause is necessary, sufficient, both, or neither.

66
New cards

Probabilistic (Stochastic) Causality

A modern epidemiological causal paradigm that incorporates randomness and variation, estimating how an exposure shifts the statistical probability of a health event rather than guaranteeing its occurrence.

67
New cards

Necessary Cause

A component causal factor whose presence is mandatory for the disease event to occur; without it, the outcome cannot develop.

68
New cards

Sufficient Cause

A minimal constellation of component causes and conditions that inevitably triggers the development of disease.

69
New cards

Rothman's Causal Pie Model

A multicausal conceptual model illustrating disease etiology as complete pie circles representing sufficient causes made of individual pie slices (component causes), where a component cause present in all pies is deemed a necessary cause.

<p>A multicausal conceptual model illustrating disease etiology as complete pie circles representing sufficient causes made of individual pie slices (component causes), where a component cause present in all pies is deemed a necessary cause.</p>
70
New cards

Web of Causation

An ecological framework modeling chronic non-communicable disease etiology as an intricate network of interconnected factors spanning social, regional, community, worksite, and individual biological determinants.

71
New cards

Internal Validity

The degree to which the design, conduct, and statistical analysis of an epidemiologic investigation accurately measures the association between exposure and outcome without distortion from bias or confounding.

72
New cards

External Validity

The degree to which the empirical results and inferences of a study can be generalized and applied to external populations, alternative settings, and different time periods.

73
New cards

Random Error

The non-systematic divergence of an observed study result from the true underlying population parameter caused by poor measurement precision, sampling error, or biological variability, assessed using pp-values.

74
New cards

pp-Value

The probability of observing a result as extreme as, or more extreme than, the study findings purely by random chance under the null hypothesis, conventionally deemed statistically significant when p<0.05p < 0.05.

75
New cards

Systematic Error (Bias)

Any non-random deviation of study results, measurements, or inferences from the truth arising from flaws in participant selection, data collection, or analytic procedures.

76
New cards

Selection Bias

A systematic distortion of an association resulting from the manner in which subjects are recruited, enrolled, or retained in a study, such that the exposure-outcome relationship differs between participants and non-participants.

77
New cards

Berkson's Bias

A form of selection bias arising in hospital-based case-control studies when differing hospital admission rates between cases and controls with different exposure statuses distort the exposure-disease odds ratio.

78
New cards

Healthy Worker Effect

A type of selection bias seen in occupational cohort studies where workers exhibit lower overall morbidity and mortality rates than the general population because severely ill individuals are excluded from employment.

79
New cards

Information Bias

A systematic error in estimating an effect measure caused by misclassification or inaccurate measurement of participant exposure status, confounders, or health outcomes.

80
New cards

Recall Bias

A type of information bias common in retrospective case-control studies where cases report or recall past exposure histories more or less accurately than controls.

81
New cards

Interviewer Bias

A systematic error occurring when study interviewers or abstractors consciously or unconsciously probe more thoroughly for past exposures among cases than among controls.

82
New cards

Observer Bias

A type of information bias where an investigator's prior knowledge of a participant's exposure status influences how they diagnose, measure, or classify the study outcome.

83
New cards

Respondent Bias

A form of information bias that occurs when a study participant systematically misreports their own outcome or disease status during data collection.

84
New cards

Confounder

An extraneous variable that distorts an association because it is independently associated with the exposure in the source population, causally associated with the outcome, and not an intermediate step on the causal pathway.

<p>An extraneous variable that distorts an association because it is independently associated with the exposure in the source population, causally associated with the outcome, and not an intermediate step on the causal pathway.</p>
85
New cards

Restriction

A design-phase technique used to control confounding by limiting study enrollment exclusively to individuals who fall within a specific range or category of the confounding factor.

86
New cards

Stratification

An analytic method to control for confounding where the study sample is separated into mutually exclusive strata of the confounding factor to assess the exposure-disease association separately within each stratum.

87
New cards

Multivariable Modeling

A mathematical regression modeling approach used in the analytic phase to estimate the independent effect of an exposure on an outcome while simultaneously controlling for multiple categorical and continuous confounders.